ETF PRO AIOctober 7, 2026
IDNA iShares Genomics Immunology and Healthcare ETF
Fund tearsheet · data as of the latest session · October 7, 2026
ONE YEAR OF DAILY CLOSES
0.47%expense ratio
$317Mfund assets
+56.1%return, YTD
+66.5%return, 1 year
+$49Mnet flow, 1 month
+$106Mnet flow, 1 year
28.7%realized volatility, 1y
-10.7%worst drawdown, 1y
Top ten holdings
| 1 | MRNA MODERNA | 11.83% |
| 2 | TWST TWIST BIOSCIENCE | 8.18% |
| 3 | GSK GSK | 2.48% |
| 4 | IOVA IOVANCE BIOTHERAPEUTICS | 4.76% |
| 5 | RVMD REVOLUTION MEDICINES | 3.84% |
| 6 | MRK MERCK & CO | 3.19% |
| 7 | REGN REGENERON PHARMACEUTICALS | 3.16% |
| 8 | IBRX IMMUNITYBIO | 3.39% |
| 9 | VRTX VERTEX PHARMACEUTICALS | 3.11% |
| 10 | EXEL EXELIXIS | 3.09% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS